About NGS
Next generation sequencing (NGS) technology is used to sequence millions of small fragments of DNA simultaneously. The technology is similar to capillary electrophoresis where the bases of small fragments of DNA are sequentially identified from signals emitted, and each fragment is resynthesized from a DNA template strand. The major difference is that NGS process is extended across millions of reactions in a massively parallel fashion, rather than restricted to a single or a few DNA fragments. This technology enables rapid sequencing of large stretches of DNA base pairs spanning entire genomes with highly sophisticated instruments capable of producing hundreds of gigabytes of data in a single sequencing run. NGS finds application in whole genome, exome, and transcriptome sequencing that provide a high-resolution and global view of various applications such as the cancer genome. NGS coupled with bioinformatics tools has revolutionized cancer research, diagnosis, and therapy. This technology helps to track and trace the spread of disease and foreign contaminants in drugs.
Technavio's analysts forecast the global next generation sequencing market to grow at a CAGR of 21.36% over the period 2014-2019.
Covered in this report
This report covers the present scenario and the growth prospects of the global next generation sequencing market for the period 2015-2019. The global next generation sequencing market is divided into two segments: equipment, and reagents and consumables. To calculate the market size, the report considers the revenue generated from the sales of equipment, and reagents and consumables used in next generation sequencing in the following customer segments:
• Commercial entities such as hospitals and pharmaceutical and life sciences companies
• Research institutes
Technavio's report, Global Next Generation Sequencing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Illumina
• Roche Diagnostics
• Thermo Fischer Scientific
Other Prominent Vendors
• 10X Genomics
• 23andMe
• Ambry Genetics
• Axeq Technologies
• Beijing Genomics Institute
• CLC bio
• Clontech Laboratories
• Fluidigm
• Foundation Medicine
• GATC Biotech
• GeneDx
• GENEWIZ
• Gnomegen
• Good Start Genetics
• Ingenuity Systems
• Knome
• NABsys
• Oxford Nanopore Technologies
• Pathogenica
• PerkinElmer
• RainDance Technologies
• Rubicon Genomics
• Sequenom
• Sigma-Aldrich
• Source Biosciences
• Takara Bio
Market Driver
• Increased Adoption by New Customers
• For a full, detailed list, view our report
Market Challenge
• Technical and Implementation Issues
• For a full, detailed list, view our report
Market Trend
• Strategic Alliances
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Genome Sequencing Cost Analysis
08. Cost of Equipment
09. Reimbursement and Coverage
10. Regulatory Point of View for NGS Tests
10.1 Analytical Performance of NGS Tests
10.2 Accessing Clinical Performance of NGS Tests
10.2.1 Leveraging Genetic Databases to Evaluate Clinical Performance
10.2.2 Communicate Information about Less Well-known Variants
11. Market Segmentation by Product
11.1 Global NGS Market by Product 2014-2019
11.2 Global NGS Market by Reagents and Consumables
11.2.1 Market Size and Forecast
11.3 Global NGS Market by Equipment
11.3.1 Market Size and Forecast
12. Market Segmentation by End-user
12.1 Global NGS Market by End-user 2014-2019
13. Market Segmentation by Technology
13.1 Global NGS Market by Technology
13.1.1 Sequencing by Synthesis
13.1.2 Ion Semiconductor Sequencing
13.1.3 Sequencing by Ligation
13.1.4 Pyrosequencing
13.1.5 SMRT Sequencing
14. Geographical Segmentation
14.1 Global NGS Market by Geographical Segmentation 2014-2019
14.2 NGS Market in Americas
14.2.1 Market Size and Forecast
14.3 NGS Market in EMEA
14.3.1 Market Size and Forecast
14.4 NGS Market in APAC
14.4.1 Market Size and Forecast
15. Buying Criteria
16. Market Growth Drivers
17. Drivers and their Impact
18. Market Challenges
19. Impact of Drivers and Challenges
20. Market Trends
21. Trends and their Impact
22. Vendor Landscape
22.1 Competitive Scenario
22.1.1 Key News
22.1.2 Mergers and Acquisitions
22.2 Market Share Analysis 2014
22.3 Other Prominent Vendors
23. Key Vendor Analysis
23.1 Illumina
23.1.1 Key Facts
23.1.2 Business Overview
23.1.3 Business Segmentation
23.1.4 Geographical Segmentation by Revenue 2013
23.1.5 Business Strategy
23.1.6 Key Information
23.1.7 SWOT Analysis
23.2 Roche Diagnostics
23.2.1 Key Facts
23.2.2 Business Overview
23.2.3 Business Segmentation by Revenue 2013
23.2.4 Geographical Segmentation by Revenue 2013
23.2.5 Business Strategy
23.2.6 Key Developments
23.2.7 SWOT Analysis
23.3 Life Technologies now part of Thermo Fisher Scientific
23.3.1 Key Facts
23.3.2 Business Overview
23.3.3 Business Segmentation by Revenue 2012
23.3.4 Geographical Segmentation by Revenue 2012
23.3.5 Business Strategy
23.3.6 Recent Developments
23.3.7 SWOT Analysis
24. Other Reports in this Series
List Of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global NGS Market 2014-2019 ($ million)
Exhibit 3: Cost per Genome 2001-2014 ($ million)
Exhibit 4: Cost per Megabase of DNA Sequence 2001-2014 ($)
Exhibit 5: Estimated Cost of NGS Equipment
Exhibit 6: Global NGS Market by Product 2014
Exhibit 7: Global NGS Market by Product 2019
Exhibit 8: Global NGS Market by Product 2014-2019
Exhibit 9: Global NGS Market by Reagents and Consumables 2014-2019 ($ million)
Exhibit 10: Global NGS Market by Equipment 2014-2019 ($ million)
Exhibit 11: Global NGS Market by End-user 2014
Exhibit 12: Global NGS Market by Geographical Segmentation 2014
Exhibit 13: Global NGS Market by Geographical Segmentation 2019
Exhibit 14: Global NGS Market by Geographical Segmentation 2014-2019
Exhibit 15: NGS Market in Americas 2014-2019 ($ million)
Exhibit 16: NGS Market in EMEA 2014-2019 ($ million)
Exhibit 17: NGS Market in APAC 2014-2019 ($ million)
Exhibit 18: Market Share Analysis 2014
Exhibit 19: Illumina: Business Segmentation
Exhibit 20: Illumina: Geographical Segmentation by Revenue 2013
Exhibit 21: Roche Diagnostics: Business Segmentation by Revenue 2013
Exhibit 22: Roche Diagnostics: Geographical Segmentation by Revenue 2013
Exhibit 23: Life Technologies: Business Segmentation by Revenue 2012
Exhibit 24: Life Technologies: Geographical Segmentation by Revenue 2012
